Why do patients with head and neck squamous cell carcinoma experience distant metastases: Can they be prevented?

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 13, Issue 2, 2005, Pages 101-104

  Zender, Chad A ^a   Petruzzelli, Guy J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer; Head and neck cancer; Metastasis; Squamous cell carcinoma

Indexed keywords

ANGIOGENIC PROTEIN; ASPARTIC PROTEINASE; CETUXIMAB; CISPLATIN; CYCLIN D1; ENDOSTATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; GELATINASE B; INTEGRIN; MATRIX METALLOPROTEINASE; SELECTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UROKINASE; UVOMORULIN;

ADJUVANT CHEMOTHERAPY; ANGIOGENESIS; APOPTOSIS; CANCER RISK; CELL ADHESION; CELL COMMUNICATION; CELL INVASION; CELL MOTILITY; CLINICAL TRIAL; HEAD AND NECK CARCINOMA; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; HEAD AND NECK NEOPLASMS; HUMANS; INTEGRINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 15244361763     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000156171.70521.dc     Document Type: Review

References (30)

1. Hart I. Metastasis. In: Oxford Textbook of Oncology. 2nd edition. Edited by Souhami RL, Tannock I, Hohenberger P, Horiot J. Cary, NC: Oxford University Press; 2002:103-113.
2. Gasparoni A, Fonzi L, Schneider GB, et al. Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Arch Oral Biol 2004; 49:653-664.
3. Behrens J, Mareel M, Van Roy FM, et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell cell adhesion. J Cell Biol 1983; 108:2435-2447.
4. Chen H, Paradies NE, Fedor-Chaiken M, et al. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J Cell Sci 1997; 110:345-356.
5. Lorch JH, Klessner J, Park JK, et al. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 2004; 279:37191-37200.
6. Chen Q, Lipkina G, Song Q, et al. Promoter methylation regulates cadherin switching in squamous cell carcinoma. Biochem Biophys Res Commun 2004; 315:850-856.
7. Huang S, Armstrong EA, Benavente S, et al. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR):combining anti-EGFR antibody with tyrosine kinase inhibitor. Cancer Res 2004; 64:5355-5362.
8. Hynes RO. Integrins: versatility, modulation and cell adhesion. Cell 1992; 69:11-25.
9. Zhang Y, Lu H, Dazin P, et al. Functional differences between integrin alpha4 and integrins alpha5/alphav in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin. Exp Cell Res 2004; 295:48-58.
10. Ramos DM, But M, Regezi J, et al. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol 2002; 21:297-307.
11. Zhou J, Zhou L, Jin X. Expression of the integrin alpha 6 beta 4 and effects of integrin alpha 6 beta4 on adhesive and invasive behaviors of human laryngeal carcinoma cell lines. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2004; 18:164-166 [Chinese].
12. Wilson RF, Morse MA, Pei P, et al. Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer Res 2003; 28:1289-1295. This study illustrates new mechanism by which endostatin may inhibit tumor growth.
13. Huang S, Armstrong EA, Benavente S, et al. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor. Cancer Res 2004; 64:5355-5362.
14. Caponigro F, Ionna F, Comella G. New cytotoxic and molecular-targeted therapies of head and neck tumors. Curr Opin Oncol 2004; 16:225-230. This excellent article discusses many of the recent advances in the medical therapies directed at head and neck cancer.
15. Shintani S, Li C, Mihara M, et al. Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells. Cancer Lett 2003; 201:149-155. This article illustrates the possible anti-metastatic activity of Gefitinib on oral cancer cells
16. Nakahara S, Miyoshi E, Noda K, et al. Involvement of oligosaccharide changes in alpha5beta1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line. Mol Cancer Ther 2003; 2:1207-1214.
17. Wu L, Chen Q, Huang W, et al. Immunohistochemical study of sialyl Lewis(a) antigen in oral squamous cell carcinoma: the association of sialyl Lewis(a) expression with local lymph metastasis. Hua Xi Kou Qiang Yi Xue Za Zhi 2003; 21:435-437 [Chinese].
18. Eshel R, Zanin A, Kapon D, et al. Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells. Int J Cancer 2002; 98:803-810.
19. Eshel R, Zanin A, Sagi-Assif O, et al. The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells. J Biol Chem 2000; 275:12833-12840.
20. Albo D, Tuszynski GP. Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. J Surg Res 2004; 120:21-26.
21. Ghosh S, Munshi HG, Sen R, et al. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma. Cancer 2002; 95:2524-2533.
22. Katayama A, Bandoh N, Kishibe K, et al. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin Cancer Res 2004; 10:634-640. This report is a nice illustration of our advances in the development of potential tumor markers for head and neck cancer.
23. Tsuchiya Y, Sawada S, Yoshioka I, et al. Increased surgical stress promotes tumor metastasis. Surgery 2003; 133:547-555.
24. Sparano A, Weinstein G, Chalian A, et al. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 2004; 131:472-476. This nice article looks at ways to increase our ability to identify those at risk for locoregional metastasis.
25. Ross GL, Soutar DS, MacDonald DG, et al. Improved staging of cervical metastases in clinically node-negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol 2004; 11:213-218.
26. Kosuda S, Kusano S, Kohno N, et al. Feasibility and cost-effectiveness of sentinel lymph node radiolocalization in stage NO head and neck cancer. Arch Otolaryngol Head Neck Surg 2003; 129:1105-1109 [Erratum in Arch Otolaryngol Head Neck Surg 2003; 129:1229]. This article not only addresses the technical ability of sentinel node biopsy to give us information but also begins to show the cost effectiveness of this innovative procedure.
27. Kyzas PA, Stefanou D, Batistatou A, et al. Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2. Mod Pathol 2004 Oct 08 (Epub ahead of print).
28. Riedel F, Gotte K, Goessler U, et al. Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines. Anticancer Res 2004; 24:2179-2183.
29. Nyberg P, Heikkila P, Sorsa T, et al. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J Biol Chem 2003; 278:22404-22411.
30. Akervall J, Kumit DM, Adams M, et al. Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck. Acta Otolaryngol 2004; 124:851-857.